Hypertension Diagnostics, Inc.
HDII
$0.00
$0.000.00%
| 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 03/31/2012 | |
|---|---|---|---|---|---|
| Revenue | 167.20K | 2.01M | 3.19M | 3.16M | 3.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 167.20K | 2.01M | 3.19M | 3.16M | 3.37M |
| Cost of Revenue | 999.00K | 2.44M | 3.38M | 3.27M | 2.86M |
| Gross Profit | -831.80K | -432.00K | -186.30K | -117.10K | 174.60K |
| SG&A Expenses | 670.00K | 1.05M | 1.18M | 1.18M | 1.06M |
| Depreciation & Amortization | 4.30K | 4.30K | 4.30K | 4.30K | 2.50K |
| Other Operating Expenses | 53.60K | 53.60K | 53.60K | 53.60K | 31.50K |
| Total Operating Expenses | 1.73M | 3.55M | 4.62M | 4.51M | 3.96M |
| Operating Income | -1.56M | -1.54M | -1.43M | -1.36M | -919.40K |
| Income Before Tax | -1.94M | -1.86M | -1.68M | -1.47M | -986.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.94 | -1.86 | -1.68 | -1.47 | -0.99 |
| Earnings from Discontinued Operations | 493.20K | 1.05M | 702.30K | 209.10K | 192.40K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.44M | -809.90K | -981.00K | -1.26M | -794.30K |
| EBIT | -1.56M | -1.54M | -1.43M | -1.36M | -919.40K |
| EBITDA | -1.40M | -1.39M | -1.30M | -1.26M | -864.60K |
| EPS Basic | -0.03 | -0.02 | -0.02 | -0.03 | -0.02 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| EPS Diluted | -0.03 | -0.02 | -0.03 | -0.04 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 209.51M | 205.43M | 196.37M | 187.31M | 178.18M |
| Average Diluted Shares Outstanding | 216.85M | 220.10M | 211.04M | 201.98M | 200.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
